Literature DB >> 23355601

Cervical cancer screening among young adult women in the United States.

Katherine B Roland1, Vicki B Benard, Ashwini Soman, Nancy Breen, Deanna Kepka, Mona Saraiya.   

Abstract

BACKGROUND: Cervical cancer screening guidelines have evolved significantly in the last decade for young adult women, with current recommendations promoting later initiation and longer intervals.
METHODS: Using self-reported cross-sectional National Health Interview Survey (NHIS) 2000-2010 data, trends in Papanicolaou (Pap) testing among women ages 18-29 years were examined. NHIS 2010 data were used to investigate age at first Pap test (N = 2,198), time since most recent Pap test (n = 1,622), and predictors of Pap testing within the last 12 months (n = 1,622).
RESULTS: The percentage of 18-year-olds who reported ever having a Pap test significantly decreased from 49.9% in 2000 to 37.9% in 2010. Mean age at first Pap test in 2010 was significantly younger for non-Hispanic black women (16.9 years), women < high school education (16.9 years), women who received the HPV vaccine (17.1 years), and women who have ever given birth (17.3 years). The majority reported their last Pap test within the previous 12 months (73.1%). Usual source of healthcare (OR, 2.31) and current birth control use (OR, 1.64) significantly increased chances of having a Pap test within the previous 12 months.
CONCLUSIONS: From 2000 to 2010, there was a gradual decline in Pap test initiation among 18-year-olds; however, in 2010, many women reported ≤12 months since last screening. Evidence-based guidelines should be promoted, as screening young adult women for cervical cancer more frequently than recommended can cause considerable harms. IMPACT: A baseline of cervical cancer screening among young adult women in the United States to assess adherence to evidence-based screening guidelines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355601      PMCID: PMC4480768          DOI: 10.1158/1055-9965.EPI-12-1266

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  46 in total

Review 1.  Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence.

Authors:  F H Stewart; C C Harper; C E Ellertson; D A Grimes; G F Sawaya; J Trussell
Journal:  JAMA       Date:  2001-05-02       Impact factor: 56.272

2.  Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.

Authors:  Maria Hewitt; Susan Devesa; Nancy Breen
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

3.  Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women.

Authors:  Elizabeth Selvin; Kate M Brett
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

4.  Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.

Authors:  Maria Hewitt; Susan S Devesa; Nancy Breen
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

5.  ACOG committee opinion. Recommendations on frequency of Pap test screening. Number 152--March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1995-05       Impact factor: 3.561

Review 6.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 7.  Cancer of the uterine cervix.

Authors:  S A Cannistra; J M Niloff
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

8.  Accuracy of patients' recall of Pap and cholesterol screening.

Authors:  S Newell; A Girgis; R Sanson-Fisher; M Ireland
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

9.  Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.

Authors:  Monica Ideström; Ian Milsom; Agneta Andersson-Ellström
Journal:  Acta Obstet Gynecol Scand       Date:  2003-08       Impact factor: 3.636

10.  The frequency of Pap smear screening in the United States.

Authors:  Brenda E Sirovich; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

View more
  11 in total

1.  Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines.

Authors:  Jennifer Tsui; Annika M Hofstetter; Karen Soren
Journal:  Prev Med       Date:  2014-03-17       Impact factor: 4.018

2.  Trends in cervical cancer incidence in younger US women from 2000 to 2013.

Authors:  Daniel C Beachler; Joseph E Tota; Michelle I Silver; Aimée R Kreimer; Allan Hildesheim; Nicolas Wentzensen; Mark Schiffman; Meredith S Shiels
Journal:  Gynecol Oncol       Date:  2016-11-26       Impact factor: 5.482

3.  Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.

Authors:  Crystale Purvis Cooper; Mona Saraiya; George F Sawaya
Journal:  Am J Prev Med       Date:  2015-07-02       Impact factor: 5.043

4.  Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.

Authors:  Mark H Stoler; R Marshall Austin; Chengquan Zhao
Journal:  J Clin Microbiol       Date:  2015-05-06       Impact factor: 5.948

5.  Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.

Authors:  K B Roland; V B Benard; A Greek; N A Hawkins; D Manninen; M Saraiya
Journal:  Prev Med       Date:  2013-04-28       Impact factor: 4.018

6.  Current cervical cancer screening knowledge, awareness, and practices among U.S. affiliated pacific island providers: opportunities and challenges.

Authors:  Julie S Townsend; Analía Romina Stormo; Katherine B Roland; Lee Buenconsejo-Lum; Susan White; Mona Saraiya
Journal:  Oncologist       Date:  2014-03-25

7.  Comparative effectiveness of two outreach strategies for cervical cancer screening.

Authors:  Erin J Aiello Bowles; Hongyuan Gao; Susan Brandzel; Susan Carol Bradford; Diana S M Buist
Journal:  Prev Med       Date:  2016-01-25       Impact factor: 4.018

8.  Overuse of papanicolaou testing among older women and among women without a cervix.

Authors:  Deanna Kepka; Nancy Breen; Jessica B King; Vicki B Benard; Mona Saraiya
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

9.  Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact.

Authors:  Andrew R Wilson; Ryan J Welch; Mia Hashibe; Jessica Greenwood; Brian Jackson; Rosemary C She
Journal:  Online J Public Health Inform       Date:  2014-12-15

10.  Cervical and Breast Cancer Screening Among Mexican Migrant Women, 2013.

Authors:  Natalie Guerrero; Xiao Zhang; Gudelia Rangel; J Eduardo Gonzalez-Fagoaga; Ana Martinez-Donate
Journal:  Prev Chronic Dis       Date:  2016-08-11       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.